Back in June, TrialSite introduced the COLCORONA study led by the Montreal Heart Institute—a Phase 3 randomized, double-blind, placebo-controlled multicenter trial evaluating the efficacy and safety of colchicine in adult patients diagnosed with COVID-19 infection;...
Decentralized Clinical Trials
Category
Medable Expands Leadership in Decentralized Trials to Drive Growth: The TrialSite Interview
TrialSite recently interviewed a group of new leaders at the white-hot, decentralized clinical trial venture called Medable. The Silicon Valley-based decentralized trials platform announced strong momentum in the first half of 2020, as clinical trials sponsors pivot...
Care Access Research Partners on Revolutionary Mobile Clinical Trial for COVID-19 Treatment
Care Access Research is a research site partner on Eli Lilly and Company’s trial, providing mobile research site capabilities to quickly scale and complete vital COVID-19 trial Care Access Research, the leader in rapid development and management of high-performing...
Beech Tree Labs Selects Curavit Clinical Research to Push Toward 100% Virtual Clinical Trials
Beech Tree Labs has developed a novel drug development platform known as resonant molecular signaling (RMS), that aims to address a wide range of illnesses by restoring normal cellular communications and correcting various imbalances triggering problems. The company...
Medable Achieves 400% Growth in First Half 2020, Expands Ecosystem for Decentralized Clinical Trials
Medable Inc., an emerging leader in the rapidly unfolding decentralized clinical trials space today announced strong momentum in the first half of 2020 as life sciences companies quickly shifted clinical trials to digital platforms in response to COVID-19....
COVID-19 & the Disruption of Clinical Trials Worldwide: Readjustment in the Works
With long-lasting effects on medical science, reports Aaron van Dorn, the COVID-19 pandemic has created massive disruptions to clinical trial research across the world. As in other aspects of life, the virus has severely affected the ability to conduct trials in safe...
Virtual Trials Grow as Organizations Battle Effects of COVID-19
By Joseph Constance As the COVID-19 pandemic continues to challenge the healthcare ecosystem, many organizations are turning to virtual, or decentralized, clinical trials to keep enrollees and staff safe while continuing their research and maintaining timelines and...
LabCorp (Covance) Makes Smart Move Acquiring Home Health Care Group to Bolster Decentralized, Patient-Centric Trials
Prior to the COVID-19 pandemic, a confluence of forces, from technological advancement to the need to transform antiquated clinical trials models led to increasing calls for “patient-centricity” and “decentralized clinical trials.” But industry sponsors are heavily...
Virtual Trials Offer a Lifeline Amidst COVID, But More than Just Flipping A Switch
By Joseph Constance The pharmaceutical industry has been quick to embrace virtual, or decentralized, clinical trials during the COVID-19 pandemic, looking to technology to keep the business of running clinical trials as close to schedule as possible. ...
Nemours Children’s Health System use of Telehealth Grows by 2,200%: Change coming to Clinical Trials Too
The COVID-19 pandemic led to a 2,200 percent increase in the use of telehealth at Nemours Children’s Health System as approximately 30,000 patients used telehealth visits in April compared to 800 the year before. The provider had telehealth as part of its electronic...
Medable Inks Second Large CRO Deal with LabCorp (Covance) to Help Clinical Trials Decentralize
COVID-19 and mobile technology platforms, not to mention virtual trials, go hand-in-hand and Medable consequently is on a tear inking a strategic alliance with LabCorp (NYSE:LH), one of the world’s largest contract research organizations (CRO). Just recently, Medable...
Emerging Decentralized Clinical Trials Mobile Platform Upstart Secures $25m and Fuel During Pivot from COVID-19
Medable, a Silicon Valley-based mobile app vendor seeking to decentralize clinical trials and reduce clinical trial timelines by 50%, has raised $25 million in funding to take their startup to the next level. The company seeks to help the drug development sector...
The Site-less Trial Commences with the Heartline Study Powered by Apple, Evidation Health & Janssen (J&J)
Johnson & Johnson’s Janssen Pharmaceutical unit inked a partnership with Apple to leverage the iPhone and FDA-complaint apps for a new study—the Heartline Study—designed to assess if apps on the iPhone and features on the Apple Watch can improve health outcomes...
21% of U.S. Adults Use a Smart Watch or Fitness Tracker, Further Evidencing the Opportunity for Decentralized Clinical Trials
According to recent research from Pew Research Center as 2020 commences about one-in-five U.S. adults (21%) report they regularly wear a smart watch or wearable fitness tracker. Based on a survey six months earlier in June, the implications are significant for...
Verily (part of Google Family) Receives FDA 510k Approval for Study Watch with Irregular Pulse Monitor
Google’s investments in life sciences become more interesting by the year. Verily, the life science venture holding under Google’s parent Alphabet (NSDQ: GOOGLE), one year ago received their first 510(k) clearance for ECG for the Verily Study Watch—as described in the...
Janssen & PRA Design First Truly 100% Mobile Virtual Trial
Janssen Pharmaceuticals and clinical research organization (CRO) PRA Health Sciences recently came together and jointly designed what is purported to be the world’s first 100% decentralized clinical trial. Based on mobile technology, the indication-seeking study...
LabCorp/Covance Market Expanded Suite of Decentralized Trial Solutions
Covance, a LabCorp (NYSE: LH) company and global contract research organization (CRO), recently announced their expanded solutions for decentralized clinical trials. This latest solution includes customized recruitment strategies, a global ecosystem of decentralized...
Google Hires Top Digital Research Cardiologist Specialist in Moves to Ultimately Expand Fitbit Medical Research Competitive Position
A prominent figure in digital healthcare (including medical devices and AI) was approached by Google Health, reporting directly to Dr. Karen DeSalvo, Chief Health Officer. Dr. Jacqueline Shreibati leaves AliveCor where she served as Chief Medical Officer to take on an...
PCM Trials: Bringing Certified Nurses to Clinical Trial Sites
With the move to patient-centric, decentralized clinical trials the services of firms such as PCM Clinical Trials become of great interest. With a deep bench of Certified Mobile Research Nurses (CMRNs), PCM Clinical Trials supports the move to patient-centricity...
Stalin Adverse Event Monitoring Clinical Trial Powered by Silicon Valley-based Mobile App Platform
The University of Connecticut (UConn) Department of Kinesiology and Hartford Healthcare selected Medable, Inc., a Palo Alto, CA, cloud-based clinical trial platform, to evaluate statin-related adverse events utilizing mobile accessible electronic patient-reported...